home.social

#celltherapy — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #celltherapy, aggregated by home.social.

fetched live
  1. DATE: August 19, 2026 at 10:01PM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND

    URL: sciencedaily.com/releases/2026

    Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease, and motor neurone disease.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AIintrabodies #intracellularantibodies #AlzheimersResearch #ParkinsonsDisease #MND #neurodegenerativediseases #biotechnews #drugdiscovery #celltherapy #neurologyInnovation

  2. 𝘐𝘮𝘮𝘶𝘯𝘦 𝘙𝘦𝘴𝘦𝘵: A bedridden patient requiring daily blood transfusions went fully symptom-free after a single CAR T-cell infusion. It is the first case of one treatment resolving 3 simultaneous autoimmune diseases at once. #Science #Wissenschaft #MedSky #Health #Biology #Immunity #Research #CellTherapy #Biotech #Gesundheit #Future #Data
    techfixated.com/car-t-cell-the

  3. UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?

    biotech.industryexaminer.com/u
    #Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews

  4. Could autologous cell therapy be a next option in treatment of diabetic kidney disease?

    Read the excellent blog post at NephJC

    nephjc.com/news/rilprencel-rea

    #CKD #Diabetes #DKD #Medicine #Nephrology #CellTherapy

  5. I've been closely following the quest for cell therapy "cures" for type 1 diabetes ever since my son was diagnosed with the disease 25 years ago.

    Here's an excellent update on research from my friend Paul Heltzel:

    diatribe.org/diabetes-research

    #diabetes #T1D #celltherapy #stemcell

  6. 🧫 Stem Cells — Jan 2026

    • Developmental origin shapes fibroblast function and scarring
    • Stem and stromal plasticity influence tumor immunity
    • Metabolic stress impairs intestinal stem cell repair
    • Organoids and engineered niches enhance lineage modeling and engraftment

    pir.sh/xMNdAR2a6e

    #StemCells #RegenerativeMedicine #CellTherapy #Biology

  7. AcouSort and MFX Collaborate on Cell Therapy

    AcouSort and MFX are collaborating to evaluate integrating AcouSort's technology with MFX's bioreactor systems. The partnership intends to improve cell therapy manufacturing efficiency, focusing on sample processing times and transfer to cell expansion. MFX is part of the EcoCAR Consortium, working with UK partners on sustainable CAR-T cell production.

    #biotech #celltherapy #lifescience #AcouSort

  8. I've been writing about research on stem-cell-derived therapies since my son was diagnosed with type 1 diabetes more than 20 years ago.

    Here's a take on off-the-shelf cell therapies that are now in early clinical trials:

    Hopes for hypoimmunity

    ericbender.co/

    #type1diabetes #T1D #parkinsons #stemcell #celltherapy

  9. 🩸 How can we improve outcomes for people with #BloodCancers?
    🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering important results for patients.
    👩‍💻 Join us online on 1 October, 10:30–12:00 CET for “Impact on Blood Cancers” and find out more!
    👩‍🔬 Featuring leading experts from the HARMONY Alliance Foundation, T2EVOLVE & EASYGEN Consortium
    🎟️ Register now 👉 europa.eu/!hdYgBh

    #BloodCancer #BigDataInHealth #IHITransformingHealth #CellTherapy

  10. Mitochondria transplantation holds promise for ischemia-reperfusion injury (>3M patients/yr). cellvie + @csem.ch built an automated, standardized process—GMP-compliant + ready for CDMO transfer. Phase I prep underway. 🔬 Thoughts from the #biotech / #celltherapy community? 📖 bit.ly/4mL5E7u

    CSEM and cellvie bring mitocho...

  11. I saw a scientifically and potentially clinically rather interesting presentation from Sniper therapeutics, this morning. But do we really need to militarize our technique and therapy names?

    What was wrong with the original name Super Engagers?
    Additionally, the mechanism of action here seems to be more 'close combat' than 'sniper'.

    #Tcells #CancerTherapy #CellTherapy

  12. Researchers developed a new method to label and track #Tcells in the body using #PETimaging and engineered receptors. This could improve understanding of #celltherapy and support safer use in future treatments: go.tum.de/935833

    #Immunotherapy

    📷V. Morath

  13. DATE: November 08, 2024 at 07:00AM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    FDA eases the way for cell and gene therapy companies

    t.co/J3hTx0sL9y

    #medtech @US_FDA #genetherapy #celltherapy

    Here are any URLs found in the article text:

    t.co/J3hTx0sL9y

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  14. DATE: November 07, 2024 at 04:59PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    FDA eases the way for cell and gene therapy companies

    t.co/J3hTx0sL9y

    #medtech @US_FDA #genetherapy #celltherapy

    Here are any URLs found in the article text:

    t.co/J3hTx0sL9y

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  15. DATE: October 25, 2024 at 07:00AM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    ESGCT 2024: Steps forward in gene and cell therapies for brain tumors

    t.co/M9da2SNzSw

    #medtech #genetherapy #celltherapy #tumor

    Here are any URLs found in the article text:

    t.co/M9da2SNzSw

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  16. DATE: October 24, 2024 at 04:00PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    ESGCT 2024: Steps forward in gene and cell therapies for brain tumors

    t.co/M9da2SO7I4

    #medtech #genetherapy #celltherapy #tumor

    Here are any URLs found in the article text:

    t.co/M9da2SO7I4

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  17. Scientists create a cell that precludes malignant growth

    Researchers at the University of Helsinki and HUS Helsinki University Hospital succeeded in creating cells whose proliferation can be controlled. The technique enables new and safe cell therapies.

    #science #medical #CellTherapy #healthcare

    helsinki.fi/en/news/genes/scie

  18. J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  19. It's been a long time coming...

    Today is both Taylor Swift's birthday & the day I get to share the story of Shelby, a 7 (now 8) year old who's in the midst of a year+ "one-time" #genetherapy that will likely cure her #betathalassemia.

    Don't miss the Taylor & Emily "The Space Gal" Calandrelli mentions, Shelby's budding #YouTube career, or how Sour Patch Kids are important for gene and #celltherapy:

    statnews.com/2023/12/13/gene-t

    #health #medicine #patient #crispr #chemo #sicklecell #scd

  20. I've written (sometimes professionally, sometimes blogging) about type 1 diabetes since my son was diagnosed more than 20 years ago. Here's my latest update on cell therapies, still the best bet for actual cures:

    ericbender.co/tag/type-1-diabe

    #type1diabetes #t1d #diabetes #celltherapy #stemcell

  21. #GeneTherapy #CellTherapy ➡️ we must ensure equitable access.

    “… if we fail to take advantage of that narrowing window, everyone loses: The inevitable hodgepodge of coverage approaches will leave many without access to transformative treatments; companies will abandon promising therapies that they can’t actually sell; and new technologies will never really take flight.”
    bloomberg.com/opinion/features